Health Discovery Corporation (OTCBB: HDVY) announced today that Support Vector Machine technology was used to take first place in solving a complex marketing problem in the recent Active Learning Challenge. The results of the Active Learning Challenge were presented this past week at the 13 th International Conference on Artificial Intelligence and Statistics, in Sardinia, Italy.

The sponsors of the Active Learning Challenge, included the European Network of Excellence, Pascal2, the French Telecom Company Orange (Euronext: FTE, NYSEFTE), Microsoft Corporation (NasdaqGS: MSFT), ETH Zurich, and the IEEE, the world’s largest professional association dedicated to advancing technological innovation and excellence for the benefit of humanity.

Teams from both industry and academia from all over the world participated in the challenge. Each team could choose any hardware, software and algorithms to solve the challenge problems. Some of the classifiers used in the Active Learning Challenge included linear classifiers, non-linear kernels, Naïve Bayes, Nearest Neighbors, Neural Networks, Bayesian Network, and Bayesian Neural Networks, Random Forests, and Support Vector Machines.

The winners of the marketing challenge included two students from the National Taiwan University, Ming-Hen Tsai and Chia-Hua Ho from the group lead by Professor Chih-Jen Lin, who successfully applied Support Vector Machines to the complex business marketing problem. The Taiwanese team finished second overall on all six challenge problems behind the team from Intel (NasdaqGS: INTC) and ahead of the team from CoreLogic (NYSE: CLGX) and eBay Inc. (NasdaqGS: EBAY).

Students under Professor Lin’s tutelage have ranked among the top participants in several past challenges, including in the 2008 IEEE World Congress of Computation Intelligence Causality Challenge and the 2009 KDD Cup, applying Support Vector Machines to a wide variety of problems.

This year the participants addressed a complex, machine learning problem of growing importance for all businesses: Building predictive models when massive amounts of unlabeled data are available and only few queries for labeled data can be placed.

In medical applications, for instance, predictive models are built to make diagnoses. For instance, blood samples or tissue images may be examined to decide whether a patient is healthy or diseased.

In the Active Learning Challenge, the participants were facing problems of document analysis, text classification, pharmacology, embryology, marketing, and ecology.

The wining strategy for the business marketing application employed Support Vector Machine technology. SVMs also ranked second on the embryology task and third on the handwriting recognition and the document analysis task, proving their versatility across many markets.

Health Discovery Corporation is a pioneer in Support Vector Technologies and has 43 issued patents and 32 pending patents in this technology and was recently awarded the prestigious MICO Award by MDB Capital Group, LLC, San Francisco, Calif., for its game-changing and disruptive technology.

About Health Discovery Corporation

Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. For more information, see www.healthdiscoverycorp.com.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks and uncertainties, including, without limitation, statements regarding future performance, opportunities and investments, and anticipated results in general. From time to time the Company may make other forward-looking statements relation to other matters, including without limitation, commercialization plans and strategic partnerships. Actual results may differ materially due to a variety of factors, including, among other things, the acceptance of our approach to applying mathematics computer science and physics into the disciplines of biology, organic chemistry and medicine and our products and technologies associated with those approaches, the ability to develop and commercialize new drugs, therapies or other products based on our approaches, and other factors set forth from time to time in the Company’s Securities and Exchange Commission filings.

All forward-looking statements and cautionary statements included in this document are made as of the date hereof based on information available to the Company as of the date hereof, and the Company assumes no obligation to update any forward-looking statement or cautionary statement.

Copyright Business Wire 2010